HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: gut.2005.066100v1 55/2/182    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Verdú, E F Articles by Collins, S M Search for Related Content PubMed PubMed Citation Articles by Verdú, E F Articles by Collins, S M Topic Collections Relevant Article

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

¹ IDRP, McMaster University, Hamilton, Canada
² Department of Nutrition and Health, Nestlé Research Centre, Lausanne, Switzerland

Correspondence to:
Correspondence to:
Dr E F Verdu
Intestinal Disease Research Program, 1200 Main S West, Hamilton, Ontario, Canada; verdue{at}mcmaster.ca

ABSTRACT
Background and aim: Abdominal pain and discomfort are common symptoms in functional disorders and are attributed to visceral hypersensitivity. These symptoms fluctuate over time but the basis for this is unknown. Here we examine the impact of changes in gut flora and gut inflammatory cell activity on visceral sensitivity.

Methods: Visceral sensitivity to colorectal distension (CRD) was assessed at intervals in healthy mice for up to 12 weeks, and in mice before and after administration of dexamethasone or non-absorbable antibiotics with or without supplementation with Lactobacillus paracasei (NCC2461). Tissue was obtained for measurement of myeloperoxidase activity (MPO), histology, microbiota analysis, and substance P (SP) immunolabelling.

Results: Visceral hypersensitivity developed over time in healthy mice maintained without sterile precautions. This was accompanied by a small increase in MPO activity. Dexamethasone treatment normalised MPO and CRD responses. Antibiotic treatment perturbed gut flora, increased MPO and SP immunoreactivity in the colon, and produced visceral hypersensitivity. Administration of Lactobacillus paracasei in spent culture medium normalised visceral sensitivity and SP immunolabelling, but not intestinal microbiota counts.

Conclusion: Perturbations in gut flora and in inflammatory cell activity alter sensory neurotransmitter content in the colon, and result in altered visceral perception. Changes in gut flora may be a basis for the variability of abdominal symptoms observed in functional gastrointestinal disorders and may be prevented by specific probiotic administration.

Abbreviations: IBS, irritable bowel syndrome; SPF, specific pathogen free; CRD, colorectal distension; MPO, myeloperoxidase; SCM, spent culture medium; SP, substance P; MRS, Man-Rogosa-Sharpe broth; EMG, electromyographic; CFU, colony forming units

Keywords: probiotic therapy; visceral hypersensitivity; gut flora; inflammation; mice

Relevant Article

Digest

Robin Spiller and Alistair Watson
Gut 2006 55: 141. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				S Vanner The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment Gut, September 1, 2008; 57(9): 1315 - 1321. [Full Text] [PDF]

				F Barreau, C Salvador-Cartier, E Houdeau, L Bueno, and J Fioramonti Long-term alterations of colonic nerve-mast cell interactions induced by neonatal maternal deprivation in rats Gut, May 1, 2008; 57(5): 582 - 590. [Abstract] [Full Text] [PDF]

				S. M. Collins Translating symptoms into mechanisms: functional GI disorders Advan Physiol Educ, December 1, 2007; 31(4): 329 - 331. [Abstract] [Full Text] [PDF]

				E. M M Quigley Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy? J. Am. Coll. Nutr., December 1, 2007; 26(6): 684S - 690S. [Abstract] [Full Text] [PDF]

				H. Eutamene, F. Lamine, C. Chabo, V. Theodorou, F. Rochat, G. E. Bergonzelli, I. Corthesy-Theulaz, J. Fioramonti, and L. Bueno Synergy between Lactobacillus paracasei and Its Bacterial Products to Counteract Stress-Induced Gut Permeability and Sensitivity Increase in Rats J. Nutr., August 1, 2007; 137(8): 1901 - 1907. [Abstract] [Full Text] [PDF]

				M. Verma-Gandhu, E. F Verdu, P. Bercik, P. A Blennerhassett, N. Al-Mutawaly, J.-E. Ghia, and S. M Collins Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse Gut, March 1, 2007; 56(3): 358 - 364. [Abstract] [Full Text] [PDF]

				A Ait-Belgnaoui, W Han, F Lamine, H Eutamene, J Fioramonti, L Bueno, and V Theodorou Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction Gut, August 1, 2006; 55(8): 1090 - 1094. [Abstract] [Full Text] [PDF]